drugset / Trial / NCT00174473

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

NCT00174473

Phase 1/2 Completed 49 enrolled Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children

Timeline

Start
2003-06
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule Intravenous

Indications